Zhongchao Inc. Implements Significant Share Consolidation as Part of Corporate Strategy

Zhongchao Inc. Announces 1-for-3 Share Consolidation

Zhongchao Inc., trading on NASDAQ under the symbol ZCMD, has recently made a significant announcement regarding the company’s share structure. This strategic decision involves a 1-for-3 consolidation of its ordinary shares, which is slated to take effect on June 29, 2026. The main objective of this move is to uphold Zhongchao's presence on the Nasdaq Capital Market, ensuring that it remains a viable investment option for shareholders.

What is Share Consolidation?

Share consolidation, often referred to as a reverse stock split, is a financial maneuver that reduces the number of a company's outstanding shares. In the case of Zhongchao, this means that three of its ordinary shares, previously valued at $0.248 each, will be consolidated into a single share that holds a par value of $0.744. This change will affect both Class A and Class B ordinary shares, impacting all shareholders equally while not altering their percentage interests in the company, apart from adjustments necessary for fractional shares.

Implications of This Move

The restructuring of the share base is part of Zhongchao's strategy to stabilize its market position and enhance shareholder confidence. With this consolidation, the company anticipates a more robust stock price, which is integral for maintaining Nasdaq listing standards. Zhongchao currently has 3,449,475 Class A and 20,161 Class B ordinary shares outstanding. Post-consolidation, the count will drop to approximately 1,149,825 Class A and 6,721 Class B shares, promoting a streamlined capital structure.

Background on Zhongchao

Zhongchao Inc. is an offshore holding company based in the Cayman Islands, focused on utilizing technology to provide healthcare solutions, primarily in the oncology sector. Its operations are structured through a series of agreements with its wholly-owned subsidiary, Zhongchao Medical Technology (Shanghai) Limited. The company's distinct approach encompasses online healthcare information services, professional training through the MDMOOC platform, and patient management services focusing on serious diseases such as tumors and rare conditions.

The services provided by Zhongchao are important not only for individual patients but also for healthcare professionals who benefit from their training and support resources. Utilizing innovative technology, the company aims to bridge gaps in patient care and enhance treatment outcomes in the complex landscape of healthcare.

Future Prospects

Moving forward, Zhongchao is projected to continue its focus on expanding its offerings and improving its market position. The share consolidation is expected to be a pivotal step in that direction, fostering investor interest and potentially supporting future growth initiatives. The company has already witnessed shareholder endorsements for this strategic initiative, which was approved by both its board of directors and shareholders on June 18, 2026.

In summary, Zhongchao Inc.'s decision to consolidate its shares marks a critical juncture for the company, demonstrating its commitment to strengthening its financial standing and optimizing shareholder value. As it navigates through these changes, stakeholders are encouraged to stay informed about the developments that may arise in the wake of this consolidation, considering the potential for new opportunities and growth in the healthcare technology landscape.

For additional information on Zhongchao or its services, interested parties can visit the investor relations section of their official website.